Regulacje i polityka gospodarcza · 02/10/2009

Availability for Licensing of Ebola Monoclonal Antibody Patent Application

The U.S. government, represented by the Secretary of the Army, has made available the licensing of a provisional patent application for monoclonal antibodies targeting the Ebola Sudan Boniface virus, filed on September 2, 2009, with patent application serial number 61/239,266.